Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ansuman T. Satpathy"'
Autor:
Crystal L. Mackall, Ravindra Majeti, Robbie G. Majzner, Ansuman T. Satpathy, Howard Y. Chang, Poul H. Sorensen, Wan-Jen Hong, Jie Liu, Htoo Zarni Oo, Mads Daugaard, Elena Sotillo, Amy Fan, Peng Xu, Kevin R. Parker, Katherine A. Freitas, Feifei Zhao, Rebecca M. Richards
Supplemental figures and legends in one document
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a648a9aba5801dbaef9a405c3d987d75
https://doi.org/10.1158/2643-3230.22543087
https://doi.org/10.1158/2643-3230.22543087
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Alternative strategies are needed for patients with B-cell malignancy relapsing after CD19-targeted immunotherapy. Here, cell surface proteomics revealed CD72 as an optimal target for poor-prognosis KMT2A/MLL1-rearranged (MLLr) B-cell acute lymphobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eda55a5274e3677f255a2fad22066d9
https://doi.org/10.1158/2159-8290.c.6548995.v1
https://doi.org/10.1158/2159-8290.c.6548995.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071cd4a9ceee3e0f3be7d0956260a267
https://doi.org/10.1158/2159-8290.22539136.v1
https://doi.org/10.1158/2159-8290.22539136.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Figure from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d17db5e546d5631791798d1c469ce4
https://doi.org/10.1158/2159-8290.22539127
https://doi.org/10.1158/2159-8290.22539127
Autor:
Nathan E. Reticker-Flynn, Weiruo Zhang, Julia A. Belk, Pamela A. Basto, Andrew J. Gentles, John B. Sunwoo, Ansuman T. Satpathy, Sylvia K. Plevritis, Edgar G. Engleman
Publikováno v:
Cancer Research. 83:3469-3469
The majority of cancer-associated deaths result from distant organ metastasis, yet the mechanisms that enable this process remain poorly understood. For most solid tumors, colonization of regional or distant lymph nodes (LNs) typically precedes the f
Autor:
Nathaniel W. Mabe, Min Huang, Daniel A. Schaefer, Guillermo N. Dalton, Giulia Digiovanni, Gabriela Alexe, Anna C. Geraghty, Delan Khalid, Marius M. Mader, Michal Sheffer, Miles H. Linde, Nghi Ly, Maria Caterina Rotiroti, Benjamin A. H. Smith, Marius Wernig, Carolyn R. Bertozzi, Michelle Monje, Constantine Mitsiades, Ravindra Majeti, Ansuman T. Satpathy, Kimberly Stegmaier, Robbie G. Majzner
Publikováno v:
Cancer Research. 82:PR003-PR003
Epigenetic dysregulation is frequently observed in the disease pathology of pediatric cancers, including neuroblastoma, the most common extracranial solid tumor in pediatric patients. Neuroblastoma tumors co-opt developmentally linked adrenergic or m
Autor:
Kamal Mandal, Jeffrey D. Whitman, Kevin R. Parker, Elliot Stieglitz, Faranak Fattahi, Aashish Manglik, Jonathan Ramirez, Veronica Steri, Yu-Hsiu T. Lin, Ansuman T. Satpathy, Anne Deucher, Makeba Marcoulis, Matthew A. Nix, Huimin Geng, Paul Phojanokong, Arun P. Wiita, Sagar P. Bapat, Byron Hann, Kristie L. White, Neha Paranjape, Jose M. Rivera
Publikováno v:
Cancer Discovery. 11:2032-2049
Alternative strategies are needed for patients with B-cell malignancy relapsing after CD19-targeted immunotherapy. Here, cell surface proteomics revealed CD72 as an optimal target for poor-prognosis KMT2A/MLL1-rearranged (MLLr) B-cell acute lymphobla
Autor:
Katherine A. Freitas, Julia A. Belk, Elena Sotillo, Bence Daniel, Katalin Sandor, Dorota Klysz, Vandon T. Duong, Peng Xu, Meena Malipatlolla, Evan W. Weber, Robbie G. Majzner, Howard Y. Chang, Ansuman T. Satpathy, Crystal Mackall
Publikováno v:
Cancer Research. 82:2822-2822
Adoptive T cell immune therapies mediate impressive clinical benefit in a fraction of patients, but anti-tumor effects are often limited by inadequate T cell potency. To identify genes that limit T cell effector function, we conducted genome-wide CRI
Autor:
Jose G. Vilches-Moure, Hima Anbunathan, Ansuman T. Satpathy, Zhongyu Zhu, Dorota Klysz, Kevin R. Parker, Peng Xu, Elena Sotillo-Pineiro, Samantha Buongervino, Alberto Delaidelli, Johanna Theruvath, Dimiter S. Dimitrov, Crystal L. Mackall, Sabine Heitzeneder, Dontcho Jelev, Anya Alag, Jennifer Hwang, John M. Maris, Shaurya Dhingra, Kristopher R. Bosse, Jing Huang, Poul H. Sorensen, Martin Hasselblatt, Robbie G. Majzner, Min Huang
Publikováno v:
Cancer Research. 81:1548-1548
Background: CAR T-cells targeting solid tumor antigens have not yet demonstrated similar success as seen for CD19, BCMA and CD22 in B-cell malignancies. Truly tumor-specific antigens are rare, yet pediatric solid tumors manifest stalled fetal develop
Autor:
Ansuman T. Satpathy, Winnie Yao
Publikováno v:
Cancer Immunology Research. 9:601-601
Understanding the cellular regulation of tumor-specific CD8+ T-cell responses is critical to designing improved clinical strategies for cancer immunotherapy. In this issue, Aoki and colleagues deepen our knowledge of this topic by demonstrating that